Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Core Viewpoint - Bionano Genomics, Inc. is expected to report a quarterly loss and specific revenue figures for the fourth quarter and fiscal year 2025 [1] Financial Performance - The company is anticipated to report a quarterly loss of $1.40 per share [1] - Expected revenue for the fourth quarter is between $7.8 million and $8.0 million, with a consensus estimate of $7.85 million [1] - For fiscal year 2025, total revenue is projected to be between $28.4 million and $28.6 million [1] Stock Information - Bionano Genomics shares closed at $1.12 on the last trading day [1]